





Excede for Swine is an antibiotic indicated for the treatment of swine respiratory disease (SRD) associated with Actinobacillus pleuropneumoniae, Pasteurella multocida, Haemophilus parasuis, and Streptococcus suis. Each ml of Excede for Swine contains ceftiofur crystalline free acid equivalent to 100 mg ceftiofur. Administer Excede for Swine by IM injection in the post-auricular region of the neck behind the ear.)
The usual recommended dosage is 1 ml suspension per 44 lbs body weight. Do not administer more than 2 ml per injection site. Injection volumes in excess of 2 ml may result in violative residues. Pigs heavier than 88 lbs will require more than one injection. Ready-to-use suspension. Shake well before using. Ceftiofur.
$156.90 Original price was: $156.90.$150.00Current price is: $150.00.
Guaranteed Safe Checkout

Managing Swine Respiratory Disease (SRD) complex in nursery, grower-finisher, and breeding swine operations is one of the most critical challenges in commercial pork production. Environmental stressors—such as weaning, commingling, temperature fluctuations, and ventilation changes—weaken a pig’s upper respiratory defenses. This physiological stress opens the door for opportunistic bacterial pathogens to colonize deep lung tissue, triggering acute bronchial inflammation, high fever, dyspnea (thumping), and severe pulmonary lesions.
Left untreated, SRD outbreaks spread rapidly through nursery and finishing pens, causing high mortality, reduced average daily gain (ADG), poor feed conversion ratios, and significant economic losses.
Traditional short-acting antibiotics require daily sorting, snaring, and repeated intramuscular injections. This frequent handling increases stress on sick pigs, raises labor overhead, and increases the risk of injection-site tissue damage.
To achieve sustained, multi-day therapeutic drug levels while keeping pig handling to a minimum, swine veterinarians rely on extended-release beta-lactam antimicrobials. Excede for Swine Sterile Suspension (manufactured by Zoetis) is a premier, broad-spectrum third-generation cephalosporin approved for the treatment and metaphylactic control of SRD. Powered by Ceftiofur Crystalline Free Acid (CCFA) at a concentration of $100\ \text{mg/mL}$, Excede for Swine utilizes a specialized oily suspension base that slowly releases active ceftiofur into circulation, delivering up to 7 days of sustained therapeutic activity from a single intramuscular injection.
This comprehensive clinical manual covers the sustained-release cephalosporin kinetics, post-auricular administration protocols, target pathogen spectrum, and precise dosing guidelines for Excede for Swine.
Excede for Swine delivers a broad-spectrum bactericidal mechanism paired with an advanced depot-release delivery system:
[Excede for Swine 100mg/ml Administered]
|
[Post-Auricular Intramuscular Injection (IM)]
|
[Slow Release of Free Acid from Depot]
|
-------------------------------------------------
| |
[SUSTAINED PLASMA DEPOT] [BACTERICIDAL CELL WALL BLOCK]
(Ceftiofur Crystalline Matrix) (Beta-Lactam Transpeptidase Inhibitor)
| |
v v
[Maintains Therapeutic Levels] [Prevents Peptidoglycan Synthesis]
(Exceeds MIC for SRD Pathogens) (Triggers Bacterial Cell Lysis)
| |
v v
[Provides up to 7 Days Coverage] [Rapid Clearance of Lung Pathogens]
| |
=========================> <=====================
|
v
[Full Resolution of Thumping & Clinical SRD]
|
[Maximized Recovery with Minimal Pig Handling]
Ceftiofur is a broad-spectrum, third-generation cephalosporin that acts bactericidally against Gram-positive and Gram-negative swine pathogens. It acts by inhibiting bacterial cell wall synthesis. Ceftiofur binds to essential penicillin-binding proteins (PBPs) involved in cross-linking the peptidoglycan cell wall layer, leading to osmotic instability, cell wall rupture, and rapid bacterial cell death.
Unlike conventional ceftiofur sodium or ceftiofur hydrochloride salts that absorb and clear rapidly, Ceftiofur Crystalline Free Acid (CCFA) is formulated in a specialized sustained-release oil base:
Slow Dissolution: Following intramuscular injection in the neck muscle behind the ear, the crystalline matrix forms a localized depot that slowly releases active ceftiofur into the capillaries over several days.
Metabolic Conversion: In the body, ceftiofur is rapidly metabolized to its primary active metabolite, desfuroylceftiofur, which retains equivalent antimicrobial activity and binds to plasma proteins to maintain extended tissue protection.
Excede for Swine provides broad-spectrum coverage against the primary bacterial causes of Swine Respiratory Disease:
Actinobacillus pleuropneumoniae (APP)
Pasteurella multocida
Haemophilus parasuis (Glasser’s Disease)
Streptococcus suis
Excede for Swine 100mg/ml is a foundational therapeutic tool across commercial pork production systems:
Treatment of Swine Respiratory Disease (SRD): Indicated for the treatment of acute SRD associated with A. pleuropneumoniae, P. multocida, H. parasuis, and S. suis.
Metaphylactic Control of SRD: Administered to groups of pigs in pens where SRD has been diagnosed, controlling the spread of disease to exposed pen-mates before severe clinical signs emerge.
Single-Injection Handling Efficiency: Provides a full course of antibacterial therapy in a single handling event, reducing stress on sick pigs and cutting labor costs.
To guarantee proper therapeutic outcomes and preserve pork food safety standards, Excede for Swine must be administered strictly according to post-auricular intramuscular guidelines.
1.Determine Accurate Pig Body Weight:Weight Assessment.
Weigh animals or use a calibrated scale tape to calculate the precise volume requirement. Avoid guessing weights to ensure correct dosing.
2.Identify Anatomical Injection Site:Post-Auricular Setup.
Locate the post-auricular region of the neck (shallow muscle directly behind the ear base). Excede for Swine is approved strictly for intramuscular injection in this specific anatomical location.
3.Inject Intramuscularly at Labeled Dose:Intramuscular Delivery.
Administer as a single Intramuscular (IM) injection in the neck behind the ear at a dose of 5.0 mg/kg body weight ($1.0\ \text{mL}$ per $44\ \text{lbs}$ / $20\ \text{kg}$ body weight).
4.Observe Site Volume Limitations:Volume Splitting.
Do not inject more than 2.0 mL into a single injection site. If the total dose exceeds 2.0 mL (pigs over $88\ \text{lbs}$ / $40\ \text{kg}$), divide the dose and administer on opposite sides of the neck.
The table below outlines standard clinical dosing parameters for Excede for Swine ($100\ \text{mg/mL}$):
| Target Animal Class | Active Dosage Rate | Volumetric Dosing Ratio | Approved Injection Route & Site | Max Volume per Site | Slaughter Withdrawal Period |
| Nursery & Grower Swine | $5.0\ \text{mg/kg}$ body weight | $1.0\ \text{mL}$ per $44\ \text{lbs}$ ($20\ \text{kg}$) | IM Only in Post-Auricular Neck | $2.0\ \text{mL}$ per site | 14 Days |
| Finisher & Breeding Swine | $5.0\ \text{mg/kg}$ body weight | $1.0\ \text{mL}$ per $44\ \text{lbs}$ ($20\ \text{kg}$) | IM Only in Post-Auricular Neck | $2.0\ \text{mL}$ per site | 14 Days |
Strict Anatomical Site Compliance: Excede for Swine must be injected in the post-auricular region of the neck. Do not inject in the ham or loin muscles, as this alters depletion kinetics and damages high-value commercial meat cuts.
Mandatory Slaughter Withdrawal Period: Swine treated with Excede must not be slaughtered for human consumption within 14 days of the last treatment.
Maximum Site Volume Limit: Do not exceed 2.0 mL per single injection site to prevent localized tissue damage and ensure uniform absorption.
Contraindications: Do not use in animals with known hypersensitivity to ceftiofur or other beta-lactam antibiotics (penicillins and cephalosporins).
Storage Parameters: Store at controlled room temperature between 20°C and 25°C (68°F to 77°F). Shake well before use to resuspend the crystalline oil base. Protect from freezing. Use within 12 weeks of first puncture.
Excede for Swine contains 100 mg/mL ceftiofur crystalline free acid and is formulated for Intramuscular (IM) injection behind the ear in pigs. Excede for Cattle contains 200 mg/mL and is formulated for Subcutaneous (SQ) injection at the base of the ear in cattle. Always use the species-specific formulation.
Excede for Swine must be administered Intramuscularly (IM) in the post-auricular neck region directly behind the base of the ear. Never inject into the hindquarters or back loin.
A single post-auricular intramuscular dose provides therapeutic drug concentrations in lung tissue above the MIC for key SRD pathogens for up to 7 days.
You can safely purchase authentic, factory-sealed Excede for Swine online through Equines Vet Care. We store and manage all inventory under strict environmental controls to guarantee absolute product stability and full therapeutic potency.
At Equines Vet Care, we understand that managing swine health requires absolute product reliability. Every vial of Excede for Swine 100mg/ml is sourced through authorized veterinary distribution networks, stored in our climate-controlled facility, and shipped securely to ensure complete product quality.
For wholesale swine accounts, commercial farm supply orders, or logistics tracking assistance, please reach out to our professional support desk directly at our contact us page.
No account yet?
Create an Account
Reviews
There are no reviews yet.